Papers
1
Total Citations
5
H-Index
1
About
Dr. Ye Xu is a leading surgical oncologist whose research focuses on the surgical management of familial adenomatous polyposis (FAP), a hereditary colorectal cancer syndrome. Dr. Xu’s work centers on refining operative strategies for patients with this autosomal dominant disease, which is driven by pathogenic germline APC mutations and characterized by hundreds of colorectal adenomas. In their highly cited 2023 update on surgical management, Dr. Xu provided a comprehensive synthesis of evolving techniques—from prophylactic colectomy to restorative proctocolectomy—and correlated specific genetic variants with distinct FAP phenotypes. This contribution has been instrumental in guiding personalized surgical decision-making, helping clinicians tailor interventions based on genotype-phenotype associations. With over 5 citations in a short period, this work underscores Dr. Xu’s impact on translating genetic insights into practical, life-saving surgical protocols. Their research bridges the gap between molecular genetics and operative oncology, offering clear guidance for managing this high-risk patient population. Dr. Xu’s dedication to advancing FAP care continues to shape best practices in hereditary colorectal cancer surgery.
Research Focus
Key Achievements
Top Papers
- 1Update on Surgical Management of FAP5 citations · 2023